Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Parmax Pharma Ltd has announced the closure of its insider trading window in line with SEBI's Prohibition of Insider Trading Regulations. This window closure typically precedes a board meeting to consider and approve financial results (quarterly, half-yearly, or annual). During this period, designated persons including directors, key managerial personnel, and connected employees are prohibited from buying, selling, or pledging the company's shares. The exact reopening date is usually disclosed once the financial results are made public. This is a standard, recurring compliance announcement and does not indicate any extraordinary corporate event.
No direct impact on retail shareholders or the stock price. This is a routine regulatory measure, but signals that financial results are likely to be announced soon, which is the only event worth watching.